Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00212537
Status:
COMPLETED
Last Update Posted:
2022-08-30
First Post:
2005-09-19
Brief Title:
Disease Modifying Genes in Severe Asthma
Sponsor:
Organization:
NYU Langone Health
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
The total amount of blood drawn is approximately 5 tablespoons 75 ml The blood sample will be processed to isolate genetic material mainly DNA RNA and protein This genetic material will be used to try to identify the genetic factors or genes that a person inherits that make him or her more likely to develop asthma The blood is used to test for allergies to weeds trees insects and molds RAST and a complete blood count
Enrollment Count:
941
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 1333 |
Who Masked List: